Bausch Health
BHC
#3380
Rank
NZ$5.77 B
Marketcap
$15.64
Share price
-0.85%
Change (1 day)
35.18%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$36.00 Billion

According to Bausch Health 's latest financial reports the company's total debt is NZ$36.00 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31NZ$35.40 B8.24%
2022-12-31NZ$32.70 B-1.38%
2021-12-31NZ$33.16 B0.02%
2020-12-31NZ$33.15 B-13.76%
2019-12-31NZ$38.44 B6.11%
2018-12-31NZ$36.23 B1.14%
2017-12-31NZ$35.82 B-16.85%
2016-12-31NZ$43.08 B-5.19%
2015-12-31NZ$45.44 B133.72%
2014-12-31NZ$19.44 B-8.06%
2013-12-31NZ$21.14 B57.79%
2012-12-31NZ$13.40 B57.28%
2011-12-31NZ$8.52 B78.11%
2010-12-31NZ$4.78 B785.91%
2009-12-31NZ$0.54 B392.04%
2008-12-31NZ$0.10 B
2006-12-31NZ$0.58 B-8.83%
2005-12-31NZ$0.63 B-4.78%
2004-12-31NZ$0.67 B-46.3%
2003-12-31NZ$1.24 B-12.47%
2002-12-31NZ$1.42 B1184.59%
2001-12-31NZ$0.11 B-93.33%
2000-12-31NZ$1.66 B533.56%
1999-12-31NZ$0.26 B9.27%
1998-12-31NZ$0.24 B2751.72%
1997-12-31NZ$8.44 M-14.78%
1996-12-31NZ$9.9 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.45 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA